Finland· FI-REL-REL4598
Gabitril
A tiagabine product containing tiagabine hydrochloride, registered in Finland by Cephalon France. The same ATC class is registered in 9 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Tiagabine is registered in 9 of 19 countries.
Countries holding a registration under ATC N03AG06 (tiagabine), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 7 of them publish a price we can compare per daily dose
Tiagabine · ATC N03AG06
9 / 19 countries
- Belgiumprice
- Finlandprice
- Franceprice
- Ireland
- Italyprice
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of tiagabine costs, country by country.
Normalised to the WHO defined daily dose (30 mg), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Tiagabine · price per daily dose (30 mg)
USD · FX 28 Sept 2026
- IT Italy$3.98
- FR France$3.35
The record
At a glance
Fimea (Finland)- Active substance
- Tiagabine hydrochloride
- Manufacturer
- Cephalon France
- Country
- Finland (FI)
- ATC code
- N03AG06
- ATC class
- Tiagabine
- Defined daily dose
- 30 mg, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
163 interactions on record for tiagabine.
Graded by severity as the source publishes them — 92 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tiagabine · interactions on record
163 records
- 92 moderate
- 46 info
Most severe, free to view
- MetoclopramideA03FA01moderate
- DiphenhydraminA04AB05moderate
- DronabinolA04AD10moderate
- NabiloneA04AD11moderate
25 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Tiagabine in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumGabitril 15 mgTeva
- SpainGABITRIL 15 mg COMPRIMIDOS RECUBIERTOS CON PELICULATeva B.V.
- FranceGABITRIL 15 mg, comprimé pelliculéTEVA PHARMA (PAYS-BAS)
- IrelandGabitril 15 mg film-coated tabletsTeva Pharma B.V.
- PolandGabitrilTeva Pharmaceuticals Polska Sp. z o.o.
- United KingdomGabitril 10mg tabletsDowelhurst Ltd
- United StatesTiagabine HydrochlorideNovadoz Pharmaceuticals LLC
- ItalyGABITRIL*50 cpr rivestite 10 mgTEVA ITALIA Srl
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Belgium · Gabitril
- Spain · Gabitril
- France · Gabitril
- United Kingdom (Northern Ireland) · Gabitril
- Ireland · Gabitril
- Italy · Gabitril
- Luxembourg · Gabitril
- Poland · Gabitril
- Portugal · Gabitril
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a847a52f-add3-4efc-ad70-a6db543579d6 GET /v1/drugs/a847a52f-add3-4efc-ad70-a6db543579d6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "30",
"form": "tabletti, kalvopäällysteinen",
"route": null,
"ddd_unit": "mg",
"strength": "15 mg",
"atc_label": "tiagabiini",
"ma_number": "12441",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL4598",
"authorised_at": "1996-12-02"
}See everything about tiagabine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.